nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Dehydration—Thiotepa—sarcoma	0.00957	0.00957	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00919	0.00919	CcSEcCtD
Ceftibuten—Dehydration—Vincristine—sarcoma	0.00848	0.00848	CcSEcCtD
Ceftibuten—Pancytopenia—Thiotepa—sarcoma	0.00844	0.00844	CcSEcCtD
Ceftibuten—Pancytopenia—Dactinomycin—sarcoma	0.00838	0.00838	CcSEcCtD
Ceftibuten—Dysuria—Thiotepa—sarcoma	0.00831	0.00831	CcSEcCtD
Ceftibuten—Dehydration—Mitoxantrone—sarcoma	0.00826	0.00826	CcSEcCtD
Ceftibuten—Neutropenia—Dactinomycin—sarcoma	0.00825	0.00825	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.0078	0.0078	CcSEcCtD
Ceftibuten—Renal failure—Thiotepa—sarcoma	0.00779	0.00779	CcSEcCtD
Ceftibuten—Jaundice—Thiotepa—sarcoma	0.00773	0.00773	CcSEcCtD
Ceftibuten—Haematuria—Thiotepa—sarcoma	0.00756	0.00756	CcSEcCtD
Ceftibuten—Pancytopenia—Vincristine—sarcoma	0.00749	0.00749	CcSEcCtD
Ceftibuten—Agranulocytosis—Thiotepa—sarcoma	0.0074	0.0074	CcSEcCtD
Ceftibuten—Dysuria—Vincristine—sarcoma	0.00737	0.00737	CcSEcCtD
Ceftibuten—Neutropenia—Vincristine—sarcoma	0.00737	0.00737	CcSEcCtD
Ceftibuten—Agranulocytosis—Dactinomycin—sarcoma	0.00734	0.00734	CcSEcCtD
Ceftibuten—Pancytopenia—Mitoxantrone—sarcoma	0.00729	0.00729	CcSEcCtD
Ceftibuten—Neutropenia—Mitoxantrone—sarcoma	0.00718	0.00718	CcSEcCtD
Ceftibuten—Haemoglobin—Thiotepa—sarcoma	0.00715	0.00715	CcSEcCtD
Ceftibuten—Haemorrhage—Thiotepa—sarcoma	0.00712	0.00712	CcSEcCtD
Ceftibuten—Rigors—Epirubicin—sarcoma	0.00699	0.00699	CcSEcCtD
Ceftibuten—Renal failure—Mitoxantrone—sarcoma	0.00673	0.00673	CcSEcCtD
Ceftibuten—Erythema multiforme—Dactinomycin—sarcoma	0.00668	0.00668	CcSEcCtD
Ceftibuten—Jaundice—Mitoxantrone—sarcoma	0.00667	0.00667	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00665	0.00665	CcSEcCtD
Ceftibuten—Haematuria—Mitoxantrone—sarcoma	0.00653	0.00653	CcSEcCtD
Ceftibuten—Rigors—Doxorubicin—sarcoma	0.00647	0.00647	CcSEcCtD
Ceftibuten—Agranulocytosis—Mitoxantrone—sarcoma	0.00639	0.00639	CcSEcCtD
Ceftibuten—Chills—Thiotepa—sarcoma	0.00638	0.00638	CcSEcCtD
Ceftibuten—Chills—Dactinomycin—sarcoma	0.00634	0.00634	CcSEcCtD
Ceftibuten—Haemoglobin—Mitoxantrone—sarcoma	0.00618	0.00618	CcSEcCtD
Ceftibuten—Haemorrhage—Mitoxantrone—sarcoma	0.00614	0.00614	CcSEcCtD
Ceftibuten—Pancytopenia—Etoposide—sarcoma	0.00606	0.00606	CcSEcCtD
Ceftibuten—Neutropenia—Etoposide—sarcoma	0.00597	0.00597	CcSEcCtD
Ceftibuten—Vaginal inflammation—Epirubicin—sarcoma	0.00571	0.00571	CcSEcCtD
Ceftibuten—Agitation—Thiotepa—sarcoma	0.00569	0.00569	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00564	0.00564	CcSEcCtD
Ceftibuten—Eructation—Epirubicin—sarcoma	0.00561	0.00561	CcSEcCtD
Ceftibuten—Renal failure—Etoposide—sarcoma	0.0056	0.0056	CcSEcCtD
Ceftibuten—Melaena—Epirubicin—sarcoma	0.00557	0.00557	CcSEcCtD
Ceftibuten—Jaundice—Etoposide—sarcoma	0.00555	0.00555	CcSEcCtD
Ceftibuten—Chills—Mitoxantrone—sarcoma	0.00551	0.00551	CcSEcCtD
Ceftibuten—Candida infection—Epirubicin—sarcoma	0.00545	0.00545	CcSEcCtD
Ceftibuten—Vaginal infection—Epirubicin—sarcoma	0.00539	0.00539	CcSEcCtD
Ceftibuten—Convulsion—Thiotepa—sarcoma	0.00537	0.00537	CcSEcCtD
Ceftibuten—Aplastic anaemia—Epirubicin—sarcoma	0.00536	0.00536	CcSEcCtD
Ceftibuten—Agranulocytosis—Etoposide—sarcoma	0.00531	0.00531	CcSEcCtD
Ceftibuten—Vaginal inflammation—Doxorubicin—sarcoma	0.00528	0.00528	CcSEcCtD
Ceftibuten—Dysgeusia—Mitoxantrone—sarcoma	0.00524	0.00524	CcSEcCtD
Ceftibuten—Eructation—Doxorubicin—sarcoma	0.00519	0.00519	CcSEcCtD
Ceftibuten—Melaena—Doxorubicin—sarcoma	0.00516	0.00516	CcSEcCtD
Ceftibuten—Agitation—Vincristine—sarcoma	0.00505	0.00505	CcSEcCtD
Ceftibuten—Candida infection—Doxorubicin—sarcoma	0.00504	0.00504	CcSEcCtD
Ceftibuten—Vaginal infection—Doxorubicin—sarcoma	0.00498	0.00498	CcSEcCtD
Ceftibuten—Aplastic anaemia—Doxorubicin—sarcoma	0.00496	0.00496	CcSEcCtD
Ceftibuten—Erythema multiforme—Etoposide—sarcoma	0.00483	0.00483	CcSEcCtD
Ceftibuten—Anorexia—Thiotepa—sarcoma	0.00482	0.00482	CcSEcCtD
Ceftibuten—Anorexia—Dactinomycin—sarcoma	0.00478	0.00478	CcSEcCtD
Ceftibuten—Convulsion—Vincristine—sarcoma	0.00476	0.00476	CcSEcCtD
Ceftibuten—Convulsion—Mitoxantrone—sarcoma	0.00463	0.00463	CcSEcCtD
Ceftibuten—Chills—Etoposide—sarcoma	0.00459	0.00459	CcSEcCtD
Ceftibuten—Paraesthesia—Thiotepa—sarcoma	0.00454	0.00454	CcSEcCtD
Ceftibuten—Somnolence—Thiotepa—sarcoma	0.00449	0.00449	CcSEcCtD
Ceftibuten—Anaphylactic shock—Vincristine—sarcoma	0.00448	0.00448	CcSEcCtD
Ceftibuten—Dyspepsia—Thiotepa—sarcoma	0.00445	0.00445	CcSEcCtD
Ceftibuten—Decreased appetite—Thiotepa—sarcoma	0.00439	0.00439	CcSEcCtD
Ceftibuten—Anaphylactic shock—Mitoxantrone—sarcoma	0.00437	0.00437	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Thiotepa—sarcoma	0.00436	0.00436	CcSEcCtD
Ceftibuten—Decreased appetite—Dactinomycin—sarcoma	0.00436	0.00436	CcSEcCtD
Ceftibuten—Fatigue—Thiotepa—sarcoma	0.00436	0.00436	CcSEcCtD
Ceftibuten—Dysgeusia—Etoposide—sarcoma	0.00436	0.00436	CcSEcCtD
Ceftibuten—Renal impairment—Epirubicin—sarcoma	0.00435	0.00435	CcSEcCtD
Ceftibuten—Fatigue—Dactinomycin—sarcoma	0.00433	0.00433	CcSEcCtD
Ceftibuten—Constipation—Thiotepa—sarcoma	0.00432	0.00432	CcSEcCtD
Ceftibuten—Anorexia—Vincristine—sarcoma	0.00427	0.00427	CcSEcCtD
Ceftibuten—Anorexia—Mitoxantrone—sarcoma	0.00416	0.00416	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Thiotepa—sarcoma	0.00413	0.00413	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Dactinomycin—sarcoma	0.0041	0.0041	CcSEcCtD
Ceftibuten—Insomnia—Vincristine—sarcoma	0.00405	0.00405	CcSEcCtD
Ceftibuten—Renal impairment—Doxorubicin—sarcoma	0.00403	0.00403	CcSEcCtD
Ceftibuten—Paraesthesia—Vincristine—sarcoma	0.00403	0.00403	CcSEcCtD
Ceftibuten—Urticaria—Thiotepa—sarcoma	0.00402	0.00402	CcSEcCtD
Ceftibuten—Abdominal pain—Thiotepa—sarcoma	0.004	0.004	CcSEcCtD
Ceftibuten—Body temperature increased—Thiotepa—sarcoma	0.004	0.004	CcSEcCtD
Ceftibuten—Abdominal pain—Dactinomycin—sarcoma	0.00397	0.00397	CcSEcCtD
Ceftibuten—Body temperature increased—Dactinomycin—sarcoma	0.00397	0.00397	CcSEcCtD
Ceftibuten—Paraesthesia—Mitoxantrone—sarcoma	0.00392	0.00392	CcSEcCtD
Ceftibuten—Decreased appetite—Vincristine—sarcoma	0.0039	0.0039	CcSEcCtD
Ceftibuten—Dyspnoea—Mitoxantrone—sarcoma	0.00389	0.00389	CcSEcCtD
Ceftibuten—Somnolence—Mitoxantrone—sarcoma	0.00388	0.00388	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Vincristine—sarcoma	0.00387	0.00387	CcSEcCtD
Ceftibuten—Fatigue—Vincristine—sarcoma	0.00386	0.00386	CcSEcCtD
Ceftibuten—Convulsion—Etoposide—sarcoma	0.00386	0.00386	CcSEcCtD
Ceftibuten—Dehydration—Epirubicin—sarcoma	0.00385	0.00385	CcSEcCtD
Ceftibuten—Dyspepsia—Mitoxantrone—sarcoma	0.00384	0.00384	CcSEcCtD
Ceftibuten—Constipation—Vincristine—sarcoma	0.00383	0.00383	CcSEcCtD
Ceftibuten—Decreased appetite—Mitoxantrone—sarcoma	0.00379	0.00379	CcSEcCtD
Ceftibuten—Fatigue—Mitoxantrone—sarcoma	0.00376	0.00376	CcSEcCtD
Ceftibuten—Constipation—Mitoxantrone—sarcoma	0.00373	0.00373	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00373	0.00373	CcSEcCtD
Ceftibuten—Hypersensitivity—Thiotepa—sarcoma	0.00372	0.00372	CcSEcCtD
Ceftibuten—Hypersensitivity—Dactinomycin—sarcoma	0.0037	0.0037	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Vincristine—sarcoma	0.00367	0.00367	CcSEcCtD
Ceftibuten—Anaphylactic shock—Etoposide—sarcoma	0.00363	0.00363	CcSEcCtD
Ceftibuten—Asthenia—Thiotepa—sarcoma	0.00363	0.00363	CcSEcCtD
Ceftibuten—Asthenia—Dactinomycin—sarcoma	0.0036	0.0036	CcSEcCtD
Ceftibuten—Pruritus—Thiotepa—sarcoma	0.00358	0.00358	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00357	0.00357	CcSEcCtD
Ceftibuten—Dehydration—Doxorubicin—sarcoma	0.00356	0.00356	CcSEcCtD
Ceftibuten—Abdominal pain—Vincristine—sarcoma	0.00354	0.00354	CcSEcCtD
Ceftibuten—Body temperature increased—Vincristine—sarcoma	0.00354	0.00354	CcSEcCtD
Ceftibuten—Urticaria—Mitoxantrone—sarcoma	0.00347	0.00347	CcSEcCtD
Ceftibuten—Anorexia—Etoposide—sarcoma	0.00346	0.00346	CcSEcCtD
Ceftibuten—Diarrhoea—Thiotepa—sarcoma	0.00346	0.00346	CcSEcCtD
Ceftibuten—Abdominal pain—Mitoxantrone—sarcoma	0.00345	0.00345	CcSEcCtD
Ceftibuten—Body temperature increased—Mitoxantrone—sarcoma	0.00345	0.00345	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00345	0.00345	CcSEcCtD
Ceftibuten—Diarrhoea—Dactinomycin—sarcoma	0.00343	0.00343	CcSEcCtD
Ceftibuten—Pancytopenia—Epirubicin—sarcoma	0.0034	0.0034	CcSEcCtD
Ceftibuten—Neutropenia—Epirubicin—sarcoma	0.00335	0.00335	CcSEcCtD
Ceftibuten—Dysuria—Epirubicin—sarcoma	0.00335	0.00335	CcSEcCtD
Ceftibuten—Dizziness—Thiotepa—sarcoma	0.00334	0.00334	CcSEcCtD
Ceftibuten—Hypersensitivity—Vincristine—sarcoma	0.0033	0.0033	CcSEcCtD
Ceftibuten—Paraesthesia—Etoposide—sarcoma	0.00326	0.00326	CcSEcCtD
Ceftibuten—Dyspnoea—Etoposide—sarcoma	0.00324	0.00324	CcSEcCtD
Ceftibuten—Somnolence—Etoposide—sarcoma	0.00323	0.00323	CcSEcCtD
Ceftibuten—Hypersensitivity—Mitoxantrone—sarcoma	0.00322	0.00322	CcSEcCtD
Ceftibuten—Asthenia—Vincristine—sarcoma	0.00322	0.00322	CcSEcCtD
Ceftibuten—Vomiting—Thiotepa—sarcoma	0.00321	0.00321	CcSEcCtD
Ceftibuten—Vomiting—Dactinomycin—sarcoma	0.00319	0.00319	CcSEcCtD
Ceftibuten—Rash—Thiotepa—sarcoma	0.00319	0.00319	CcSEcCtD
Ceftibuten—Dermatitis—Thiotepa—sarcoma	0.00318	0.00318	CcSEcCtD
Ceftibuten—Headache—Thiotepa—sarcoma	0.00317	0.00317	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00316	0.00316	CcSEcCtD
Ceftibuten—Rash—Dactinomycin—sarcoma	0.00316	0.00316	CcSEcCtD
Ceftibuten—Decreased appetite—Etoposide—sarcoma	0.00316	0.00316	CcSEcCtD
Ceftibuten—Pancytopenia—Doxorubicin—sarcoma	0.00315	0.00315	CcSEcCtD
Ceftibuten—Renal failure—Epirubicin—sarcoma	0.00314	0.00314	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Etoposide—sarcoma	0.00314	0.00314	CcSEcCtD
Ceftibuten—Asthenia—Mitoxantrone—sarcoma	0.00313	0.00313	CcSEcCtD
Ceftibuten—Fatigue—Etoposide—sarcoma	0.00313	0.00313	CcSEcCtD
Ceftibuten—Jaundice—Epirubicin—sarcoma	0.00311	0.00311	CcSEcCtD
Ceftibuten—Constipation—Etoposide—sarcoma	0.00311	0.00311	CcSEcCtD
Ceftibuten—Dysuria—Doxorubicin—sarcoma	0.0031	0.0031	CcSEcCtD
Ceftibuten—Neutropenia—Doxorubicin—sarcoma	0.0031	0.0031	CcSEcCtD
Ceftibuten—Diarrhoea—Vincristine—sarcoma	0.00307	0.00307	CcSEcCtD
Ceftibuten—Haematuria—Epirubicin—sarcoma	0.00304	0.00304	CcSEcCtD
Ceftibuten—Nausea—Thiotepa—sarcoma	0.003	0.003	CcSEcCtD
Ceftibuten—Diarrhoea—Mitoxantrone—sarcoma	0.00299	0.00299	CcSEcCtD
Ceftibuten—Nausea—Dactinomycin—sarcoma	0.00298	0.00298	CcSEcCtD
Ceftibuten—Agranulocytosis—Epirubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Etoposide—sarcoma	0.00297	0.00297	CcSEcCtD
Ceftibuten—Dizziness—Vincristine—sarcoma	0.00296	0.00296	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00293	0.00293	CcSEcCtD
Ceftibuten—Renal failure—Doxorubicin—sarcoma	0.0029	0.0029	CcSEcCtD
Ceftibuten—Urticaria—Etoposide—sarcoma	0.00288	0.00288	CcSEcCtD
Ceftibuten—Haemoglobin—Epirubicin—sarcoma	0.00288	0.00288	CcSEcCtD
Ceftibuten—Jaundice—Doxorubicin—sarcoma	0.00288	0.00288	CcSEcCtD
Ceftibuten—Body temperature increased—Etoposide—sarcoma	0.00287	0.00287	CcSEcCtD
Ceftibuten—Abdominal pain—Etoposide—sarcoma	0.00287	0.00287	CcSEcCtD
Ceftibuten—Haemorrhage—Epirubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Ceftibuten—Vomiting—Vincristine—sarcoma	0.00285	0.00285	CcSEcCtD
Ceftibuten—Rash—Vincristine—sarcoma	0.00283	0.00283	CcSEcCtD
Ceftibuten—Dermatitis—Vincristine—sarcoma	0.00282	0.00282	CcSEcCtD
Ceftibuten—Haematuria—Doxorubicin—sarcoma	0.00282	0.00282	CcSEcCtD
Ceftibuten—Headache—Vincristine—sarcoma	0.00281	0.00281	CcSEcCtD
Ceftibuten—Vomiting—Mitoxantrone—sarcoma	0.00278	0.00278	CcSEcCtD
Ceftibuten—Agranulocytosis—Doxorubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Ceftibuten—Rash—Mitoxantrone—sarcoma	0.00275	0.00275	CcSEcCtD
Ceftibuten—Dermatitis—Mitoxantrone—sarcoma	0.00275	0.00275	CcSEcCtD
Ceftibuten—Headache—Mitoxantrone—sarcoma	0.00273	0.00273	CcSEcCtD
Ceftibuten—Erythema multiforme—Epirubicin—sarcoma	0.00271	0.00271	CcSEcCtD
Ceftibuten—Hypersensitivity—Etoposide—sarcoma	0.00268	0.00268	CcSEcCtD
Ceftibuten—Haemoglobin—Doxorubicin—sarcoma	0.00266	0.00266	CcSEcCtD
Ceftibuten—Nausea—Vincristine—sarcoma	0.00266	0.00266	CcSEcCtD
Ceftibuten—Haemorrhage—Doxorubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Ceftibuten—Asthenia—Etoposide—sarcoma	0.00261	0.00261	CcSEcCtD
Ceftibuten—Nausea—Mitoxantrone—sarcoma	0.00259	0.00259	CcSEcCtD
Ceftibuten—Chills—Epirubicin—sarcoma	0.00257	0.00257	CcSEcCtD
Ceftibuten—Pruritus—Etoposide—sarcoma	0.00257	0.00257	CcSEcCtD
Ceftibuten—Erythema multiforme—Doxorubicin—sarcoma	0.00251	0.00251	CcSEcCtD
Ceftibuten—Diarrhoea—Etoposide—sarcoma	0.00248	0.00248	CcSEcCtD
Ceftibuten—Flatulence—Epirubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Ceftibuten—Dysgeusia—Epirubicin—sarcoma	0.00244	0.00244	CcSEcCtD
Ceftibuten—Dizziness—Etoposide—sarcoma	0.0024	0.0024	CcSEcCtD
Ceftibuten—Chills—Doxorubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Ceftibuten—Vomiting—Etoposide—sarcoma	0.00231	0.00231	CcSEcCtD
Ceftibuten—Agitation—Epirubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Ceftibuten—Rash—Etoposide—sarcoma	0.00229	0.00229	CcSEcCtD
Ceftibuten—Dermatitis—Etoposide—sarcoma	0.00229	0.00229	CcSEcCtD
Ceftibuten—Headache—Etoposide—sarcoma	0.00227	0.00227	CcSEcCtD
Ceftibuten—Flatulence—Doxorubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Ceftibuten—Dysgeusia—Doxorubicin—sarcoma	0.00226	0.00226	CcSEcCtD
Ceftibuten—Convulsion—Epirubicin—sarcoma	0.00216	0.00216	CcSEcCtD
Ceftibuten—Nausea—Etoposide—sarcoma	0.00216	0.00216	CcSEcCtD
Ceftibuten—Agitation—Doxorubicin—sarcoma	0.00212	0.00212	CcSEcCtD
Ceftibuten—Dry mouth—Epirubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Ceftibuten—Anaphylactic shock—Epirubicin—sarcoma	0.00204	0.00204	CcSEcCtD
Ceftibuten—Convulsion—Doxorubicin—sarcoma	0.002	0.002	CcSEcCtD
Ceftibuten—Anorexia—Epirubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Ceftibuten—Dry mouth—Doxorubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Ceftibuten—Anaphylactic shock—Doxorubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Ceftibuten—Insomnia—Epirubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Ceftibuten—Paraesthesia—Epirubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Ceftibuten—Dyspnoea—Epirubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Ceftibuten—Somnolence—Epirubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Ceftibuten—Anorexia—Doxorubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Ceftibuten—Dyspepsia—Epirubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Ceftibuten—Decreased appetite—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Epirubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Ceftibuten—Fatigue—Epirubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Ceftibuten—Constipation—Epirubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Ceftibuten—Insomnia—Doxorubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Ceftibuten—Paraesthesia—Doxorubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Ceftibuten—Dyspnoea—Doxorubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Ceftibuten—Somnolence—Doxorubicin—sarcoma	0.00167	0.00167	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Epirubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Ceftibuten—Dyspepsia—Doxorubicin—sarcoma	0.00166	0.00166	CcSEcCtD
Ceftibuten—Decreased appetite—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00163	0.00163	CcSEcCtD
Ceftibuten—Fatigue—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Ceftibuten—Urticaria—Epirubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Ceftibuten—Constipation—Doxorubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Ceftibuten—Abdominal pain—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Ceftibuten—Body temperature increased—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Doxorubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Ceftibuten—Hypersensitivity—Epirubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Ceftibuten—Urticaria—Doxorubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Ceftibuten—Body temperature increased—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Ceftibuten—Abdominal pain—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Ceftibuten—Asthenia—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Ceftibuten—Pruritus—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Ceftibuten—Diarrhoea—Epirubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Ceftibuten—Hypersensitivity—Doxorubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Ceftibuten—Asthenia—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Ceftibuten—Dizziness—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Ceftibuten—Pruritus—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Ceftibuten—Vomiting—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Ceftibuten—Diarrhoea—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Ceftibuten—Rash—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Ceftibuten—Dermatitis—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Ceftibuten—Headache—Epirubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Ceftibuten—Dizziness—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Ceftibuten—Nausea—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Ceftibuten—Vomiting—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Ceftibuten—Rash—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Ceftibuten—Dermatitis—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Ceftibuten—Headache—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Ceftibuten—Nausea—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
